| GLNLX | RSLDX | GLNLX / RSLDX | |
| Total Expense Ratio | 1.35 | 0.80 | 169% |
| Annual Report Gross Expense Ratio | 1.81 | 0.80 | 226% |
| Fund Existence | 14 years | 10 years | - |
| Gain YTD | 9.797 | 15.972 | 61% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 70.6M | 82.3B | 0% |
| Annual Yield % from dividends | 0.36 | 0.76 | 47% |
| Returns for 1 year | 4.24 | 9.27 | 46% |
| Returns for 3 years | 30.98 | 37.09 | 84% |
| Returns for 5 years | 7.22 | 3.80 | 190% |
| Returns for 10 years | 71.31 | 77.25 | 92% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBP | 78.37 | 1.01 | +1.30% |
| Virtus LifeSci Biotech Products ETF | |||
| QWLD | 143.17 | 0.91 | +0.64% |
| SPDR® MSCI World StrategicFactors ETF | |||
| ACP | 5.42 | 0.01 | +0.18% |
| abrdn Income Credit Strategies Fund | |||
| EMB | 96.31 | 0.07 | +0.07% |
| iShares JP Morgan USD Em Mkts Bd ETF | |||
| ZJAN | 27.25 | N/A | N/A |
| Innovator Equity Defined Protection ETF - 1 Yr January | |||